Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Previous close
$1,260.00
Day range
$1,270.00 - $1,355.00
Year range
$436.00 - $1,355.00
Market cap
206.40B TWD
Avg Volume
1.54M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 227.48M | -6.62% |
Net income | -175.56M | 19.64% |
Net profit margin | — | — |
Earnings per share | -1.10 | — |
EBITDA | -221.97M | 5.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.55B | 169.12% |
Total assets | 9.66B | 164.37% |
Total liabilities | 95.36M | -23.10% |
Total equity | 9.56B | — |
Shares outstanding | 154.61M | — |
Price to book | 20.38 | — |
Return on assets | -5.85% | — |
Return on capital | -5.90% | — |
Cash Flow
Net change in cash
| (TWD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -175.56M | 19.64% |
Cash from operations | -118.07M | 26.31% |
Cash from investing | 2.51B | 277,414.14% |
Cash from financing | 4.16M | 471.10% |
Net change in cash | 2.40B | 1,575.70% |
Free cash flow | -88.28M | 5.38% |
About
Founded
2012
Website
